Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06334185
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-21
First Post:
2024-03-20
Brief Title:
Evaluation of Vaccination for Streptococcus Pneumoniae in Adults With an Episode of Invasive Pneumococcal Infection
Sponsor:
Azienda Ospedaliera di Lecco
Organization:
Azienda Ospedaliera di Lecco
Study Overview
Official Title:
Evaluation of Vaccination for Streptococcus Pneumoniae in Adults With an Episode of Invasive Pneumococcal Infection a Retrospective Study in Two Lombardy Centers in the Pre-pandemic Phase From 2015 to 2019
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
pVax
Brief Summary:
Respiratory tract infections are among the leading causes of death worldwide and many of these infections are preventable through vaccination One of the most important bacteria from an etiological and mortality point of view regarding respiratory and systemic infections is the gram-positive Streptococcus pneumoniae Four types of vaccines are currently available for this pathogen three pneumococcal conjugate vaccines PCV13 PCV15 and PCV20 and one polysaccharide vaccine PPSV23 In Italy people over 65 years of age and people suffering from chronic pathologies with effects on the immune system would be advised to be vaccinated with the pneumococcal conjugate vaccine and with the polysaccharide vaccine as a second dose
However there are no data available in Italy on vaccination coverage in these population categories and above all the vaccination rates in patients who have a history of an episode of invasive pneumococcal infection are not known The aim of the study is to measure how many patients are vaccinated for S pneumoniae after hospitalization for a systemic pneumococcal infection in order to understand patients awareness of preventing this infection after receiving a first diagnosis
However there are no data available in Italy on vaccination coverage in these population categories and above all the vaccination rates in patients who have a history of an episode of invasive pneumococcal infection are not known The aim of the study is to measure how many patients are vaccinated for S pneumoniae after hospitalization for a systemic pneumococcal infection in order to understand patients awareness of preventing this infection after receiving a first diagnosis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None